Robert Berman
Director/Board Member bei Osmol Therapeutics, Inc.
Profil
Robert Berman is currently a Director at Osmol Therapeutics, Inc. He was previously a Director-Global Clinical Research at Bristol Myers Squibb Co. from 2003 to 2013 and an Associate Director-Clinical Sciences at Pfizer Inc. from 2000 to 2003.
He also served as the Head-Special Projects & Medical Oversight at Biohaven Pharmaceutical Holding Co. Ltd.
Additionally, he was the President of Biohaven Medical Services LLC from 2013 to 2015.
Berman received his undergraduate degree from Yale University and his graduate degree from Icahn School of Medicine at Mount Sinai.
Aktive Positionen von Robert Berman
| Unternehmen | Position | Beginn |
|---|---|---|
Osmol Therapeutics, Inc.
 Osmol Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Osmol Therapeutics, Inc. provides health care services. It develops therapy for Chemotherapy Induced Peripheral Neuropathy and Neurologic Impairment. The company was founded in 2016 and is headquartered in New Haven, CT. | Director/Board Member | - |
Ehemalige bekannte Positionen von Robert Berman
| Unternehmen | Position | Ende |
|---|---|---|
Biohaven Medical Services LLC
 Biohaven Medical Services LLC Pharmaceuticals: MajorHealth Technology Biohaven Medical Services LLC is a biopharmaceutical company that focuses on scientific innovation and prioritizes the needs of patients. Biohaven Medical Services is based in New Haven, CT. The private company's portfolio includes treatments for various diseases with unmet medical needs. The company has a scientific advisory board made up of key opinion leaders who guide their research and drug development. | President | 01.11.2015 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.11.2013 |
| PFIZER, INC. | Corporate Officer/Principal | 01.09.2003 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Robert Berman
| Yale University | Undergraduate Degree |
| Icahn School of Medicine at Mount Sinai | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
Osmol Therapeutics, Inc.
Osmol Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Osmol Therapeutics, Inc. provides health care services. It develops therapy for Chemotherapy Induced Peripheral Neuropathy and Neurologic Impairment. The company was founded in 2016 and is headquartered in New Haven, CT. | Commercial Services |
Biohaven Medical Services LLC
Biohaven Medical Services LLC Pharmaceuticals: MajorHealth Technology Biohaven Medical Services LLC is a biopharmaceutical company that focuses on scientific innovation and prioritizes the needs of patients. Biohaven Medical Services is based in New Haven, CT. The private company's portfolio includes treatments for various diseases with unmet medical needs. The company has a scientific advisory board made up of key opinion leaders who guide their research and drug development. | Health Technology |
